Rapillo Costanza Maria, Dunet Vincent, Pistocchi Silvia, Salerno Alexander, Darioli Vincent, Bartolini Bruno, Hajdu Steven David, Michel Patrik, Strambo Davide
Stroke Center, Service of Neurology, Department of Clinical Neuroscience (C.M.R., A.S., P.M., D.S.), University Hospital of Lausanne and University of Lausanne, Switzerland.
Stroke Unit, Careggi University Hospital, Florence, Italy (C.M.R.).
Stroke. 2024 May;55(5):1329-1338. doi: 10.1161/STROKEAHA.123.045154. Epub 2024 Mar 15.
The relative value of computed tomography (CT) and magnetic resonance imaging (MRI) in acute ischemic stroke (AIS) is debated. In May 2018, our center transitioned from using CT to MRI as first-line imaging for AIS. This retrospective study aims to assess the effects of this paradigm change on diagnosis and disability outcomes.
We compared all consecutive patients with confirmed diagnosis of AIS admitted to our center during the MRI-period (May 2018-August 2022) and an identical number of patients from the preceding CT-period (December 2012-April 2018). Univariable and multivariable analyses were performed to evaluate outcomes, including the number and delay of imaging exams, the rate of missed strokes, stroke mimics treated with thrombolysis, undetermined stroke mechanisms, length of hospitalization, and 3-month disability.
The median age of the 2972 included patients was 76 years (interquartile range, 65-84), and 46% were female. In the MRI-period, 80% underwent MRI as first acute imaging. The proportion of patients requiring a second acute imaging modality for diagnostic ± revascularization reasons increased from 2.1% to 5% ( <0.05), but it decreased in the subacute phase from 79.0% to 60.1% ( <0.05). In thrombolysis candidates, there was a 2-minute increase in door-to-imaging delay ( <0.05). The rates of initially missed AIS diagnosis was similar (3.8% versus 4.4%, =0.32) and thrombolysis in stroke mimics decreased by half (8.6% versus 4.3%; <0.05). Rates of unidentified stroke mechanism at hospital discharge were similar (22.8% versus 28.1%; =0.99). The length of hospitalization decreased from 9 (interquartile range, 6-14) to 7 (interquartile range, 4-12) days (=0.62). Disability at 3 months was similar (common adjusted odds ratio for favorable Rankin shift, 0.98 [95% CI, 0.71-1.36]; =0.91), as well as mortality and symptomatic intracranial hemorrhage.
A paradigm shift from CT to MRI as first-line imaging for AIS seems feasible in a comprehensive stroke center, with a minimally increased delay to imaging in thrombolysis candidates. MRI was associated with reduced thrombolysis rates of stroke mimics and subacute neuroimaging needs.
计算机断层扫描(CT)和磁共振成像(MRI)在急性缺血性卒中(AIS)中的相对价值存在争议。2018年5月,我们中心从使用CT转变为将MRI作为AIS的一线成像检查。这项回顾性研究旨在评估这一模式转变对诊断和残疾结局的影响。
我们比较了在MRI时期(2018年5月至2022年8月)入住我们中心的所有确诊AIS的连续患者,以及前一个CT时期(2012年12月至2018年4月)相同数量的患者。进行单变量和多变量分析以评估结局,包括成像检查的数量和延迟、漏诊卒中的发生率、接受溶栓治疗的类卒中、未确定的卒中机制、住院时间和3个月时的残疾情况。
纳入的2972例患者的中位年龄为76岁(四分位间距,65 - 84岁),46%为女性。在MRI时期,80%的患者接受MRI作为首次急性成像检查。因诊断±血管再通原因需要进行第二次急性成像检查的患者比例从2.1%增加到5%(P<0.05),但在亚急性期从79.0%降至60.1%(P<0.05)。在溶栓候选患者中,从就诊到成像的延迟增加了2分钟(P<0.05)。最初漏诊AIS的发生率相似(3.8%对4.4%,P = 0.32),类卒中的溶栓率降低了一半(8.6%对4.3%;P<0.05)。出院时未确定卒中机制的发生率相似(22.8%对28.1%;P = 0.99)。住院时间从9天(四分位间距,6 - 14天)降至7天(四分位间距,4 - 12天)(P = 0.62)。3个月时的残疾情况相似(改良Rankin量表良好转归的共同校正优势比,0.98 [95%CI,0.71 - 1.36];P = 0.91),死亡率和有症状颅内出血情况也相似。
在综合卒中中心,从CT转变为将MRI作为AIS的一线成像检查似乎是可行的,溶栓候选患者的成像延迟仅略有增加。MRI与类卒中的溶栓率降低和亚急性神经成像需求减少相关。